<DOC>
	<DOC>NCT00439868</DOC>
	<brief_summary>This study will be conducted in healthy volunteers to investigate the effect on intraocular pressure of 2 weeks of treatment with 300mg WELLBUTRIN XL/day.</brief_summary>
	<brief_title>A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular Pressure</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Healthy males or females. Nonsmokers Agree to remain in the clinic for the time defined in the protocol. Normal ECG. Any serious medical disorder or condition. Any history of an endocrine disorder. Any clinically significant laboratory abnormality. History of psychiatric illness. Any history of suicidal attempts or behavior. Risk factors for precipitation of angle closure glaucoma or elevated IOP. Inability to refrain from use of contact lenses during the study days, if correction is required. Selfadministered Beck Depression Inventory II scale total score greater than 9, and a suicide question score of greater than zero. Current or past history of seizure disorder or brain injury (traumatic or diseaserelated); or any condition which, in the opinion of the investigator, predisposes to seizure Women having a positive serum HCG pregnancy test at screening, a positive urine pregnancy test before admission to the Unit during the inhouse periods, who are not willing to use acceptable methods of contraception or who are lactating or planning to become pregnant within the three months following the screening visit.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>WELLBUTRIN XL, intraocular pressure, healthy volunteers</keyword>
</DOC>